We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The government commissions the ACMD to conduct an updated harms assessment of synthetic cathinones.
First published during the 2022 to 2024 Sunak Conservative government
The government commissions the ACMD to advise on the appropriate classification and scheduling of Isotonitazene and related compounds.
The government’s response to the ACMD’s fentanyl report.
First published during the 2019 to 2022 Johnson Conservative government
This ACMD report, released on 21 September 2010, considers the issue of anabolic steroid misuse. Also available are the annexes to the report…
Review of the evidence on the use and harms of xylazine, medetomidine and detomidine.
Advice on preventing drug misuse among vulnerable groups of people, with a focus on understanding factors that contribute to vulnerability.
The Advisory Council on the Misuse of Drugs (ACMD) has today (12 March) published a major report on powdered cocaine and its impact on British society.
Letter from the Advisory Council on the Misuse of Drugs (ACMD) to the Home Office about the future use and purpose of Temporary Class Drug Orders (TCDOs).
Report from the ACMD Recovery Committee exploring what outcomes we can expect from people recovering from drug and alcohol dependency.
Letter to Victoria Atkins MP from the chair of the Advisory Council on the Misuse of Drugs outlining recommendations for amending the safe custody regulations.
Methylamphetamine is a member of a broad class of psycho-stimulant compounds called amphetamines.
An assessment of the impact of rescheduling CBPMs to Schedule 2 under the Misuse of Drugs Regulations 2001 (MDR) and recommendations to mitigate the issues identified.
A review of the evidence of use and harm of Methiopropamine (MPA) by the Advisory Council on the Misuse of Drugs (ACMD).
The government responds to a report by the Advisory Council on the Misuse of Drugs (ACMD) regarding the classification and schedule of remimazolam (Byfavo).
Lynne Featherstone writes to the chair of Advisory Council on the Misuse of Drugs (ACMD) about the rescheduling of ketamine.
Letter to the Home Secretary on the consideration of oripavine.
ACMD work programme 2024 letter to the Home Secretary from the Chair of the Advisory Council on the Misuse of Drugs (ACMD).
Government response to the report by the Advisory Council on the Misuse of Drugs on acyl piperazine opioids, including 2-methyl-AP-237.
Recommendations for a temporary class drug order on a number of methylphenidate-based novel psychoactive substances.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).